|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's Range||107.57 - 112.11|
|52 Week Range||71.74 - 140.91|
|Beta (3Y Monthly)||1.21|
|PE Ratio (TTM)||29.17|
|Earnings Date||Jul 29, 2019 - Aug 2, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||136.00|
Amedisys, Inc. (AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the 2019 RBC Capital Markets Healthcare Conference in New York City, NY on Tuesday, May 21, 2019. Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care.
Amedisys Inc NASDAQ/NGS:AMEDView full report here! Summary * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is low for AMED with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold AMED had net inflows of $310 million over the last one-month. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Zacks.com featured highlights include: Exantas Capital, Lamb Weston, Bristol-Myers Squibb, Amedisys and Computer Programs and Systems
BATON ROUGE, La., May 08, 2019 -- Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home health, hospice and personal care company, commends bipartisan legislation.
Amedisys, Inc. (AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the Bank of America Merrill Lynch 2019 Healthcare Conference in Las Vegas, NV on Tuesday, May 14, 2019. Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care.
Brokers have more understanding of fundamentals of a company, and also about the overall economy. So, following broker advice is a wise decision.
Amedisys, Inc. (AMED), one of the nation’s leading home healthcare, hospice and personal care companies, celebrates National Nurses Week by honoring more than 7,000 nurses who call the company home. National Nurses Week begins each year on May 6 and ends on May 12, Florence Nightingale’s birthday. Amedisys is proud to recognize and applaud the home health, hospice and personal care nurses who provide compassionate, clinically distinct care throughout the 38 states we serve.
The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.
At Home Health and Hospice divisions, Amedisys (AMED) witnesses solid year-over-year growth in Medicare and non-Medicare revenues.
Amedisys (AMED) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
NEW YORK, NY / ACCESSWIRE / May 1, 2019 / Amedisys, Inc. (NASDAQ: AMED ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 1, 2019 at 11:00 AM Eastern Time. ...
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! If you own shares in Amedisys, Inc. (NASDAQ:AMED) then it's worth thinking about how it contributes t...
The Baton Rouge, Louisiana-based company said it had net income of 95 cents per share. Earnings, adjusted for non-recurring costs, came to $1.11 per share. The results beat Wall Street expectations. The ...
BATON ROUGE, La., April 30, 2019 -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2019. Three Month Periods.
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities over the years (that's why their assets under management continue to swell). We believe hedge fund sentiment should serve as a crucial tool of an […]
Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.